CRBP
Price
$11.54
Change
-$0.34 (-2.86%)
Updated
Nov 28 closing price
Capitalization
202.56M
Intraday BUY SELL Signals
NRSN
Price
$1.19
Change
+$0.02 (+1.71%)
Updated
Nov 28 closing price
Capitalization
34.57M
116 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRBP vs NRSN

Header iconCRBP vs NRSN Comparison
Open Charts CRBP vs NRSNBanner chart's image
Corbus Pharmaceuticals Holdings
Price$11.54
Change-$0.34 (-2.86%)
Volume$199.01K
Capitalization202.56M
NeuroSense Therapeutics
Price$1.19
Change+$0.02 (+1.71%)
Volume$70.83K
Capitalization34.57M
CRBP vs NRSN Comparison Chart in %
CRBP
Daily Signal:
Gain/Loss:
NRSN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRBP vs. NRSN commentary
Nov 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a StrongBuy and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 29, 2025
Stock price -- (CRBP: $11.54 vs. NRSN: $1.19)
Brand notoriety: CRBP and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 48% vs. NRSN: 24%
Market capitalization -- CRBP: $202.56M vs. NRSN: $34.57M
CRBP [@Biotechnology] is valued at $202.56M. NRSN’s [@Biotechnology] market capitalization is $34.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBP is a better buy in the long-term than NRSN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish while NRSN’s TA Score has 5 bullish TA indicator(s).

  • CRBP’s TA Score: 5 bullish, 5 bearish.
  • NRSN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CRBP and NRSN are a good buy in the short-term.

Price Growth

CRBP (@Biotechnology) experienced а -3.91% price change this week, while NRSN (@Biotechnology) price change was +8.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

NRSN is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($203M) has a higher market cap than NRSN($34.6M). NRSN YTD gains are higher at: -0.833 vs. CRBP (-2.203). NRSN has higher annual earnings (EBITDA): -8.55M vs. CRBP (-57.15M). CRBP has more cash in the bank: 117M vs. NRSN (666K). NRSN has less debt than CRBP: NRSN (19K) vs CRBP (2.46M). CRBP (0) and NRSN (0) have equivalent revenues.
CRBPNRSNCRBP / NRSN
Capitalization203M34.6M587%
EBITDA-57.15M-8.55M668%
Gain YTD-2.203-0.833264%
P/E RatioN/AN/A-
Revenue00-
Total Cash117M666K17,568%
Total Debt2.46M19K12,926%
FUNDAMENTALS RATINGS
CRBP: Fundamental Ratings
CRBP
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBPNRSN
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signal:
Gain/Loss:
NRSN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MNMD12.650.55
+4.55%
Mind Medicine (MindMed)
ADBE320.132.61
+0.82%
Adobe
IRTC188.011.35
+0.72%
iRhythm Technologies
OMCC5.04N/A
N/A
Old Market Capital Corporation
PKBK22.89-0.03
-0.11%
Parke Bancorp

NRSN and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRSN has been loosely correlated with NEVPF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NRSN jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+1.71%
NEVPF - NRSN
49%
Loosely correlated
N/A
PBM - NRSN
39%
Loosely correlated
-2.85%
SLRX - NRSN
32%
Poorly correlated
+1.62%
CTMX - NRSN
31%
Poorly correlated
+1.42%
DNLI - NRSN
29%
Poorly correlated
+0.36%
More